Company Filing History:
Years Active: 2014
Title: Rémi Meyruiex: Innovator in Microencapsulation Technology
Introduction
Rémi Meyruiex is a notable inventor based in Lyons, France. He has made significant contributions to the field of pharmaceutical technology, particularly in the area of microencapsulation. His innovative work focuses on improving the delivery of active principles that have low solubility, which is crucial for effective oral medication.
Latest Patents
Meyruiex holds a patent for "Microcapsules with modified release of active principles with low solubility for oral delivery." This invention addresses the challenge of delivering poorly soluble active ingredients, excluding anti-hyperglycemia agents. The microcapsules feature a core of the active principle surrounded by a specialized coating film. This coating is designed to ensure reliable modified release and is suitable for industrial reproduction. The microcapsules have a mean diameter of less than 1000 microns and include a combination of film-forming polymers, water-soluble polymers, and plasticizers, ensuring optimal performance in gastrointestinal environments.
Career Highlights
Rémi Meyruiex is associated with Flamel Technologies, a company known for its advancements in drug delivery systems. His work at Flamel Technologies has positioned him as a key player in the development of innovative pharmaceutical solutions. His patent reflects his commitment to enhancing the efficacy of oral medications through advanced microencapsulation techniques.
Collaborations
Meyruiex has collaborated with notable colleagues such as Florence Guimberteau and Catherine Castan. These partnerships have contributed to the successful development and implementation of his innovative ideas in the pharmaceutical industry.
Conclusion
Rémi Meyruiex's contributions to microencapsulation technology represent a significant advancement in the field of pharmaceuticals. His innovative patent addresses critical challenges in drug delivery, showcasing his expertise and commitment to improving patient outcomes.